biperiden has been researched along with Anoxemia in 1 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishimura, M | 1 |
| Akiyama, Y | 1 |
| Kawakami, Y | 1 |
1 trial available for biperiden and Anoxemia
| Article | Year |
|---|---|
[Involvement of cholinergic mechanism in respiratory chemosensitivity to CO2 in humans].
Topics: Adolescent; Adult; Biperiden; Carbon Dioxide; Chemoreceptor Cells; Humans; Hypercapnia; Hypoxia; Mal | 1992 |